Pharmacopsychiatry 2018; 51(03): 82-88
DOI: 10.1055/s-0043-116855
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Prediction Model of Serum Lithium Concentrations

Kazunari Yoshida
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
,
Hiroyuki Uchida
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
2   Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada
,
Takefumi Suzuki
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
3   Department of Psychiatry, Inokashira Hospital, Tokyo, Japan
,
Masahiro Watanabe
4   School of Pharmacy, Syujitsu University, Okayama, Japan
,
Nariyasu Yoshino
5   School of Pharmacy, Nihon University, Chiba, Japan
,
Hitoshi Houchi
6   Department of Pharmacy, Kagawa University Hospital, Kagawa, Japan
,
Masaru Mimura
1   Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
,
Noriyasu Fukuoka
5   School of Pharmacy, Nihon University, Chiba, Japan
› Author Affiliations
Further Information

Publication History

received 16 March 2017
revised 30 June 2017

accepted 13 July 2017

Publication Date:
02 August 2017 (online)

Abstract

Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL).

Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects.

Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L.

Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.

 
  • References

  • 1 Suppes T, Dennehy EB, Hirschfeld RMA. et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005; 66: 870-886
  • 2 McAllister-Williams RH. Relapse prevention in bipolar disorder: A critical review of current guidelines. J Psychopharmacol. 2006; 20: 12-16
  • 3 Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs 2009; 23: 331-349
  • 4 Deacon B, Abramowitz J. Fear of needles and vasovagal reactions among phlebotomy patients. J Anxiety Disord. 2006; 20: 946-960
  • 5 Sienaert P, Geeraerts I, Wyckaert S. How to initiate lithium therapy a systematic review of dose estimation and level prediction methods. J Affect Disord. 2013; 146: 15-33
  • 6 Pepin SM, Baker DE, Nance KS. Proceedings of the 15th Annual ASHP midyear clinical meeting, San Francisco, CA, December 1980.
  • 7 Zetin M, Garber D, De Antonio M. et al. Prediction of lithium dose: A mathematical alternative to the test-dose method. J Clin Psychiatry. 1986; 47: 175-178
  • 8 Abou-Auda HS, Al-Yamani MJ, Abou-Shaaban RR. et al. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. Bipolar Disord. 2008; 10: 369-376
  • 9 Radhakrishnan R, Kanigere M, Menon J. et al. Comparison of three a-priori models in the prediction of serum lithium concentration. Indian J Pharmacol. 2012; 44: 234-235
  • 10 Terao T, Okuno K, Okuno T. et al. A simpler and more accurate equation to predict daily lithium dose. J Clin Psychopharmacol. 1999; 19: 336-340
  • 11 Cooper TB, Bergner PE, Simpson GM. The 24-hour serum lithium level as a prognosticator of dosage requirements. Am J Psychiatry. 1973; 130: 601-603
  • 12 Mason RW, McQueen EG, Keary PJ. et al. Pharmacokinetics of lithium: Elimination half-time, renal clearance and apparent volume of distribution in schizophrenia. Clin Pharmacokinet. 1978; 3: 241-246
  • 13 Huang HC, Chang YL, Lan TH. et al. Prediction of optimal lithium doses for Taiwanese psychiatric patients. J Clin Pharm Ther. 2008; 33: 115-121
  • 14 Pharmaceuticals and Medical Devices Agency. PMDA alert for proper use of drugs.Available at http://www.pmda.go.jp/files/000153187.pdf Accessed on: January 7, 2017
  • 15 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
  • 16 Winter EM. Basic clinical pharmacokinetics (Japanese). Toyko: JIHO Co Ltd; 2005: 95-98
  • 17 Interview Form of LIMAS® (Japanese). http://medical.taishotoyama.co.jp/data/if/pdf/li.pdf Accessed on: March 3, 2017
  • 18 Sampson M, Ruddel M, Elin RJ. Lithium determinations evaluated in eight analyzers. Clin Chem. 1994; 40: 869-872
  • 19 Aliasgharpour M, Hagani H. Evaluation of lithium determination in three analyzers: Flame emission, flame atomic absorption spectroscopy and ion selective electrode. N Am J Med Sci. 2009; 1: 244-246
  • 20 Delattre IK, Van de Walle P, Van Campenhout C. et al. How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme. Clin Biochem. 2015; 48: 617-621
  • 21 Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981; 9: 503-512
  • 22 Jermain DM, Crismon ML, Martin ES. Population pharmacokinetics of lithium. Clin Pharm. 1991; 10: 376-381
  • 23 Yukawa E, Nomiyama N, Higuchi S. et al. Lithium population pharmacokinetics from routine clinical data: Role of patient characteristics for estimating dosing regimens. Ther Drug Monit. 1993; 15: 75-82
  • 24 Higuchi S. Fact of TDM for drug dosage design. In: Iga T, Saito Y. eds. Tokyo: Yakugyozihousha Co Ltd; 1993: 274-292
  • 25 Thomsen K, Shirley DG. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 1997; 77: 125-138
  • 26 Grant MS. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J Emerg Nurs. 2003; 29: 116-121
  • 27 DasGupta K, Jefferson JW, Kobak KA. et al. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry. 1992; 53: 398-400
  • 28 Finley PR. Drug interactions with lithium: An update. Clin Pharmacokinet. 2016; 55: 925-941
  • 29 Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with Lithium. Clin Pharmacokinet. 1995; 29: 172-191
  • 30 Alderman CP, Lindsay KS. Increased serum lithium concentration secondary to treatment with tiaprofenic acid fosinopril. Ann Pharmacother. 1996; 30: 1411-1413
  • 31 Imbs JL, Barthelmebs M, Danion JM. et al. Mechanisms of drug interactions with renal elimination of lithium. Bull Acad Natl Med. 1997; 181: 685-695
  • 32 Wing YK, Chan E, Chan K. et al. Lithium pharmacokinetics in Chinese manic-depressive patients. J Clin Psychopharmacol. 1997; 17: 179-184
  • 33 Yang YY, Yeh EK, Chang SS. et al. Maintenance lithium levels could be lowered: Based on Taiwanese and Danish studies. J Formos Med Assoc. 1991; 90: 509-513